clinical trial · NCT00649818
Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg
HealthyLorazepam Tablets 2 mgAtivan Tablets 2 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan's lorazepam 2 mg tablets to Wyeth's Ativan 2 mg tablets following a single, oral 2 mg (1 x 2 mg) dose administered under fasting conditions.
started
Dec 1, 2004
primary completion
Dec 1, 2004
completion
Dec 1, 2004
last updated
Apr 24, 2024
official title
Single-Dose Fasting In Vivo Bioequivalence Study of Lorazepam Tablets (2 mg; Mylan) and Ativan Tablets (2 mg; Wyeth) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol